Terns Pharmaceuticals Competitors and Similar CompaniesClear all
Novartis's competitors and similar companies include Rigel Pharmaceuticals.
 Novartis Novartis is a company that researches, develops, manufactures, and markets healthcare products. |  Rigel Pharmaceuticals Rigel Pharmaceuticals develops small-molecule drugs for the treatment of autoimmune diseases, cancer and metabolic diseases. | |
Founding Date | Founding Date 1996 | Founding Date 1996 |
Type | Type Public | Type Public |
Tags | ||
Locations | Locations Basel, CH HQ Tirana, AL Buenos Aires, AR Macquarie Park, AU Kundl, AT Unterlangkampfen, AT Wien, AT see more | Locations South San Francisco, US HQ |
Employees | Employees 75,883 | Employees 1633% increase |
Financial | ||
Revenue (est.) | Revenue (est.) $56.7b (FY, 2025) | Revenue (est.) $294.3m (FY, 2025) |
Cost of goods | Cost of goods $8.4b (FY, 2025) | Cost of goods $19.6m (FY, 2025) |
Gross profit | Gross profit $49.8b (FY, 2025) | Gross profit $274.7m (FY, 2025) |
Net income | Net income $14b (FY, 2025) | Net income $367m (FY, 2025) |
Funding | ||
Total funding raised | Total funding raised $ 6.5m | Total funding raised $ 130m |
For sources of this data, please see the company profile
View Company Profiles
Rigel Pharmaceuticals
HQ
South San Francisco, US
Employees
163↑ 3% increase
Rigel Pharmaceuticals develops small-molecule drugs for the treatment of autoimmune diseases, cancer and metabolic diseases.
View company